FolioObs › IMMUCELL CORP (ICCC) › Earnings calls

IMMUCELL CORP earnings calls

ICCC · every analyst question and management's answer

Aug 14, 2026 earnings call — Focus on First Defense and capacity expansion

Announced an approximately $8 million investment to expand freeze-drying and colostrum processing capacity.

Revenue $0.0B (est $0.0B) · EPS $0.20 (est $0.05)

Key quotes

"Since we introduced this focus on First Defense and enhanced our yield improvement efforts, we have accelerated our growth and increased our share."

— P. F. Te Boekhorst (CEO) · Focus on First Defense

"The new processes are expected to reduce total processing time from 2 to 3 months today to less than 1 month in the future and more than triple our current capacity."

— P. F. Te Boekhorst (CEO) · Capacity expansion

"As Tim also noted, we incurred approximately $150,000 of scrap related to a relatively minor purchased material."

— P. F. Te Boekhorst (CEO) · Yield and quality focus

Analyst Q&A 5

Re-Tain investigational study timing

Q: The analyst asked for an update on the Re-Tain study and whether Michigan State gave a timeline for completion.

A: They asked Michigan State to investigate an additional use case and the study is ongoing. Management said the study should be completed around end of September, maybe even beginning of October, and they will share full results with investors then.

"Discussions about the interim results are ongoing, and it will not be completed until, I would say, end of September, maybe even beginning of October." — P. F. Te Boekhorst (CEO)

Why two big customers' share fell

Q: The analyst asked whether the drop in percent from the two primary customers was caused by adding salespeople.

A: They sell through distributors and have a commercial team that wins new customers who then order through those distributors. Management said shifts in which distributors show up are about timing and where new customers are located, not a purposeful change by the company, and they noted strong recent customer acquisition.

"But it's more a question of a little bit of timing and just where those new customers happen to be located and which distributors those new customers prefer to use than a purposeful change on our end." — P. F. Te Boekhorst (CEO)

Re-Tain data and licensing plans

Q: The analyst asked if Re-Tain data are collected and if the company has prepared a package for possible licensing.

A: They are awaiting results of the investigational study by Michigan State before making decisions about Re-Tain. Management expects the study to be completed in the September, October time frame and will decide after seeing those results.

"So we're, in fact, awaiting the results of the investigational study by Michigan State, which we expect to be completed September, October time frame before we make any further decisions on our Re-Tain product." — P. F. Te Boekhorst (CEO)

Seasonality and sell-through growth details

Q (George Melas · MKH Management): He asked about seasonality differences between dairy and beef and whether the 24% sell-through growth was from the two big distributors or from all distributors and how long they have tracked it.

A: Different distributors have strengths by industry and geography; the company ensures national distribution coverage and focuses on winning new customers. Dairy use is year-round, beef has a calving season causing peaks in Q4 and Q1, and the 24% figure is volume growth out-the-door by all distributors from national data the company purchases and has had access to for years.

"So the 24% growth is volume growth out-the-door by all our distributors." — P. F. Te Boekhorst (CEO)

Margin impact and building cost detail

Q: The analyst asked whether the Re-Tain-related margin impact is recurring and whether the dollar amount is fixed.

A: Management said the recurring impact is fair to expect and explained Q2 showed a larger percentage effect because revenue was smaller and the dollar amount was slightly higher. They said the amount reflects building costs — mainly utilities and depreciation — which are pretty stable but can vary a bit with utility bills and maintenance.

"So it's utilities, depreciation associated with the building." — Timothy Fiori (CFO)

AI-generated notes on the earnings call transcript. Quotes are taken from the transcript. This is not a FolioObs investment view.

IMMUCELL CORP (ICCC) · Earnings calendar

Other earnings calls this week

  • GOOGL · ALPHABET INC — Gemini 4 models and Cloud TPU scaling
  • AMZN · AMAZON.COM INC — AWS AI growth and company results
  • MSFT · MICROSOFT CORP — Copilot expansion and AI-driven Azure growth
  • GOOG · ALPHABET INC-CL C — Gemini 4 launch and Cloud TPU scaling
  • V · VISA INC — Tokenization, VAS growth, and agentic commerce focus
  • MA · MASTERCARD INCORPORATED — Network expansion and agentic commerce push
  • SPGI · S&P GLOBAL INC — Strategic review of Capital IQ and data businesses
  • DASH · DOORDASH INC - A — Instacart deal and DashMart expansion

All of this week's earnings call summaries

FolioObs Features | 주요 기능

  • Dashboard — SEC 13F Portfolio Tracker, FolioObs 50 | 대시보드
  • AI Insights — Portfolio Analysis & Signals | AI 인사이트
  • Insider Trading — SEC Form 4 Tracker | 내부자 거래
  • Cathie Wood Today's Trades + AI Insights | 캐시 우드 오늘의 매매
  • ARK Invest Report — Daily Trades | ARK 리포트
  • Investment News — Data-Driven Updates | 뉴스
  • Weekly Report — Market Movers | 주간 리포트
  • How to Read a 13F — 5-Minute Guide | 13F 읽는 법
  • The FolioObs 50 — All Tracked Investors | FolioObs 50 전체 보기
  • Wall Street Consensus — Shared Holdings | 월가 컨센서스
  • US Politician Trades — STOCK Act | 정치인 매매 추적
  • Earnings Calendar | 실적 발표 캘린더
  • This Week's Earnings Call Summaries | 이번 주 어닝콜 한 줄 요약

FolioObs 50 | 추적 중인 월가 투자자 50인

  • Warren Buffett — Berkshire Hathaway | 워렌 버핏
  • Cathie Wood — ARK Invest | 캐시 우드
  • Stanley Druckenmiller — Duquesne Family Office | 스탠리 드러켄밀러
  • Ray Dalio — Bridgewater Associates | 레이 달리오
  • George Soros — Soros Fund Management | 조지 소로스
  • Bill Ackman — Pershing Square Capital | 빌 애크먼
  • David Tepper — Appaloosa Management | 데이비드 테퍼
  • Chase Coleman — Tiger Global Management | 체이스 콜먼
  • Dan Loeb — Third Point | 댄 로엡
  • Seth Klarman — Baupost Group | 세스 클라만
  • National Pension Service (NPS) — Korea National Pension Service | 국민연금
  • David Einhorn — Greenlight Capital | 데이비드 아인혼
  • John Paulson — Paulson & Co | 존 폴슨
  • Howard Marks — Oaktree Capital Management | 하워드 막스
  • Leon Cooperman — Omega Family Office | 레온 쿠퍼먼
  • Ken Griffin — Citadel | 켄 그리핀
  • Steve Cohen — Point72 Asset Management | 스티브 코헨
  • Li Lu — Himalaya Capital | 리 루
  • Mohnish Pabrai — Pabrai Investment Funds | 모니시 파브라이
  • Bruce Berkowitz — Fairholme Capital Management | 브루스 버코비츠
  • Nelson Peltz — Trian Fund Management | 넬슨 펠츠
  • Carl Icahn — Icahn Capital | 칼 아이칸
  • Paul Singer — Elliott Management | 폴 싱어
  • Philippe Laffont — Coatue Management | 필립 라퐁
  • Andreas Halvorsen — Viking Global | 안드레아스 할보르센
  • Daniel Sundheim — D1 Capital | 다니엘 선드하임
  • Masayoshi Son — SoftBank Group | 손정의
  • Terry Smith — Fundsmith | 테리 스미스
  • Joel Greenblatt — Gotham Asset Management | 조엘 그린블랫
  • Bill Miller — Miller Value Partners | 빌 밀러
  • Brad Gerstner — Altimeter Capital | 브래드 거스트너
  • Rajiv Jain — GQG Partners | 라지브 자인
  • Duan Yongping — H&H International | 돤융핑
  • Chris Hohn — TCI Fund Management | 크리스 혼
  • Stephen Mandel — Lone Pine Capital | 스티븐 만델
  • Prem Watsa — Fairfax Financial | 프렘 왓사
  • Sequoia Fund — Ruane Cunniff & Goldfarb | 세쿼이아 펀드
  • Guy Spier — Aquamarine Capital | 가이 스파이어
  • Lee Ainslie — Maverick Capital | 리 아인슬리
  • David Abrams — Abrams Capital | 데이비드 아브람스
  • Pat Dorsey — Dorsey Asset Management | 팻 도시
  • Dev Kantesaria — Valley Forge Capital | 데브 칸테사리아
  • Francois Rochon — Giverny Capital | 프랑수아 로숑
  • Thomas Russo — Gardner Russo & Quinn | 토마스 루소
  • Tweedy Browne — Tweedy Browne | 트위디 브라운
  • Temasek — Temasek Holdings | 테마섹
  • Saudi PIF — Public Investment Fund | 사우디 국부펀드
  • Baillie Gifford — Baillie Gifford | 베일리 기포드
  • Ron Baron — Baron Capital | 론 배런
  • Thomas Gayner — Markel Group | 토마스 게이너